Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
22,107,985
-
Total 13F shares
-
16,433,840
-
Share change
-
+996,044
-
Total reported value
-
$116,615,990
-
Put/Call ratio
-
26%
-
Price per share
-
$7.02
-
Number of holders
-
74
-
Value change
-
+$7,083,278
-
Number of buys
-
37
-
Number of sells
-
30
Institutional Holders of Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) as of Q3 2024
As of 30 Sep 2024,
Adverum Biotechnologies, Inc. - Common Stock, $0.0001 par value per share (ADVM) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
16,433,840 shares.
The largest 10 holders included
BML Capital Management, LLC, TCG Crossover Management, LLC, FRANKLIN RESOURCES INC, BlackRock, Inc., VR Adviser, LLC, Frazier Life Sciences Management, L.P., VANGUARD GROUP INC, Vivo Capital, LLC, 5AM Venture Management, LLC, and GEODE CAPITAL MANAGEMENT, LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.